Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dipankar Ray

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
The Journal of Biological Chemistry|July 31, 2013
Destabilization of the epidermal growth factor receptor (EGFR) by a peptide that inhibits EGFR binding to heat shock protein 90 and receptor dimerizationAarif Ahsan, Dipankar Ray, Susmita G Ramanand, et al.
Cancer Research|February 7, 2007
Deregulated CDC25A expression promotes mammary tumorigenesis with genomic instabilityDipankar Ray, Yasuhisa Terao, Peter G Fuhrken, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 27, 2017
Unraveling biophysical interactions of radiation pneumonitis in non-small-cell lung cancer via Bayesian network analysisYi Luo, Issam El Naqa, Daniel L McShan, et al.
JCI Insight|December 8, 2020
Immune determinants of Barrett's progression to esophageal adenocarcinomaKiran H Lagisetty, Dyke P McEwen, Derek J Nancarrow, et al.
JCI Insight|May 23, 2024
ISG15/GRAIL1/CD3 axis influences survival of patients with esophageal adenocarcinomaDyke P McEwen, Paramita Ray, Derek J Nancarrow, et al.
Translational Oncology|January 5, 2021
TNFR1 and the TNFα axis as a targetable mediator of liver injury from stereotactic body radiation therapyMatthew M Cousins, Emily Morris, Christopher Maurino, et al.
Neoplasia (New York, N.Y.)|September 7, 2012
Wild-type EGFR is stabilized by direct interaction with HSP90 in cancer cells and tumorsAarif Ahsan, Susmita G Ramanand, Christopher Whitehead, et al.
Oncotarget|September 11, 2016
Differential protein stability of EGFR mutants determines responsiveness to tyrosine kinase inhibitorsParamita Ray, Yee Sun Tan, Vishal Somnay, et al.
Molecular Cancer Research : MCR|February 20, 2025
SMURF2 Facilitates GAP17 Isoform 1 Membrane Displacement to Promote Mutant p53-KRAS Oncogenic SynergyParamita Ray, Shirish Shukla, Yaqing Zhang, et al.
The Journal of Biological Chemistry|March 11, 2026
ISGylation of γH2AX retains MDC1 and facilitates homologous recombination repair causing radioresistance in esophageal adenocarcinomaArchismaan Ghosh, Paramita Ray, Dafydd Thomas, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
The Journal of Biological Chemistry|July 31, 2013
Destabilization of the epidermal growth factor receptor (EGFR) by a peptide that inhibits EGFR binding to heat shock protein 90 and receptor dimerizationAarif Ahsan, Dipankar Ray, Susmita G Ramanand, et al.
Cancer Research|February 7, 2007
Deregulated CDC25A expression promotes mammary tumorigenesis with genomic instabilityDipankar Ray, Yasuhisa Terao, Peter G Fuhrken, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 27, 2017
Unraveling biophysical interactions of radiation pneumonitis in non-small-cell lung cancer via Bayesian network analysisYi Luo, Issam El Naqa, Daniel L McShan, et al.
JCI Insight|December 8, 2020
Immune determinants of Barrett's progression to esophageal adenocarcinomaKiran H Lagisetty, Dyke P McEwen, Derek J Nancarrow, et al.
JCI Insight|May 23, 2024
ISG15/GRAIL1/CD3 axis influences survival of patients with esophageal adenocarcinomaDyke P McEwen, Paramita Ray, Derek J Nancarrow, et al.
Translational Oncology|January 5, 2021
TNFR1 and the TNFα axis as a targetable mediator of liver injury from stereotactic body radiation therapyMatthew M Cousins, Emily Morris, Christopher Maurino, et al.
Neoplasia (New York, N.Y.)|September 7, 2012
Wild-type EGFR is stabilized by direct interaction with HSP90 in cancer cells and tumorsAarif Ahsan, Susmita G Ramanand, Christopher Whitehead, et al.
Oncotarget|September 11, 2016
Differential protein stability of EGFR mutants determines responsiveness to tyrosine kinase inhibitorsParamita Ray, Yee Sun Tan, Vishal Somnay, et al.
Molecular Cancer Research : MCR|February 20, 2025
SMURF2 Facilitates GAP17 Isoform 1 Membrane Displacement to Promote Mutant p53-KRAS Oncogenic SynergyParamita Ray, Shirish Shukla, Yaqing Zhang, et al.
The Journal of Biological Chemistry|March 11, 2026
ISGylation of γH2AX retains MDC1 and facilitates homologous recombination repair causing radioresistance in esophageal adenocarcinomaArchismaan Ghosh, Paramita Ray, Dafydd Thomas, et al.
Pageof 6